Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
Mead AJ. et al, (2013), Blood, 121, 4156 - 4165
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Lu M. et al, (2013), Cancer Cell, 23, 618 - 633
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation.
Plummer R. et al, (2013), Cancer Chemother Pharmacol, 71, 1191 - 1199
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia: a reply to a rebuttal.
Psaila B. et al, (2013), J Thromb Haemost, 11, 1002 - 1003
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.
Ong CC. et al, (2013), J Natl Cancer Inst, 105, 606 - 607
Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.
Camarata M. et al, (2013), BMJ Case Rep, 2013
IMCgp100: a novel bispecific biologic for the treatment of malignant melanoma.
Middleton M. et al, (2013), CANCER RESEARCH, 73
Feasibility of trials in ovarian cancer by line of therapy and platinum sensitivity.
Shaboodien R. et al, (2013), Int J Gynecol Cancer, 23, 481 - 487
MOLECULAR AND CELLULAR EFFECTS OF ONCOGENE COOPERATION IN A GENETICALLY ACCURATE AML MOUSE MODEL
Reckzeh K. et al, (2013), ANNALS OF HEMATOLOGY, 92, S1 - S2
A study to evaluate the cause of bone demineralization in gynecological cancer survivors.
Stavraka C. et al, (2013), Oncologist, 18, 423 - 429
CONTINUOUS LOW-FLOW ASCITES-DRAINAGE AND SEQUENTIAL NON-INVASIVE TUMOR-CELL SAMPLING THROUGH THE URINARY BLADDER VIA THE ALFA-PUMP CLOSED SYSTEM IN PLATINUM-RESISTANT-OVARIAN-CANCER (PROC)
Fotopoulou C. et al, (2013), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23
Early stage mucinous ovarian carcinomas: 10 years of experience in a tertiary centre
Chatterjee J. et al, (2013), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 120, 282 - 283
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma
Collins GP. et al, (2013), British Journal of Haematology
Management of ascites via the alfa-pump closed system in platinum-resistant-ovarian-cancer (PROC): A model of sequential non-invasive tumor-cell sampling through the urinary bladder
Fotopoulou C. et al, (2013), CLINICAL CANCER RESEARCH, 19
Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary team.
Cubitt JJ. et al, (2013), J Skin Cancer, 2013
New treatment approaches in melanoma: current research and clinical prospects.
Rughani MG. et al, (2013), Ther Adv Med Oncol, 5, 73 - 80
OUTCOMES IN MUCINOUS OVARIAN CARCINOMAS: 10 YEARS OF EXPERIENCE IN A TERTIARY CENTRE
Hopkins TG. et al, (2013), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23
THE IMPACT OF OVARIAN CANCER TREATMENT ON WOMEN'S SEXUAL WELLBEING
Hopkins TG. et al, (2013), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.
Eyre T. et al, (2012), Blood, 120, 4441 - 4443